This completed Phase IIb trial tested an oral drug called elismetrep (K-304) in 431 adults with moderate or severe migraine. Participants received one of four doses of elismetrep or a placebo. The main goal was to see if the drug could make pain disappear within a set time. Secon…
Phase: PHASE2 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 13:20 UTC